Nakano, K.; Fujita, S.; Hiramatsu-Asano, S.; Nagasu, A.; Tsuji, S.; Koide, Y.; Yamada, M.; Mizuta, Y.; Ikeda, M.; Hirano, H.;
et al. Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry. J. Clin. Med. 2025, 14, 1553.
https://doi.org/10.3390/jcm14051553
AMA Style
Nakano K, Fujita S, Hiramatsu-Asano S, Nagasu A, Tsuji S, Koide Y, Yamada M, Mizuta Y, Ikeda M, Hirano H,
et al. Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry. Journal of Clinical Medicine. 2025; 14(5):1553.
https://doi.org/10.3390/jcm14051553
Chicago/Turabian Style
Nakano, Kazuhisa, Shunichi Fujita, Sumie Hiramatsu-Asano, Akiko Nagasu, Shoko Tsuji, Yuka Koide, Masatomo Yamada, Yo Mizuta, Masakatsu Ikeda, Hiroyasu Hirano,
and et al. 2025. "Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry" Journal of Clinical Medicine 14, no. 5: 1553.
https://doi.org/10.3390/jcm14051553
APA Style
Nakano, K., Fujita, S., Hiramatsu-Asano, S., Nagasu, A., Tsuji, S., Koide, Y., Yamada, M., Mizuta, Y., Ikeda, M., Hirano, H., & Morita, Y.
(2025). Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry. Journal of Clinical Medicine, 14(5), 1553.
https://doi.org/10.3390/jcm14051553
